Olivia Brayer Saunders

Stock Analyst at Cantor Fitzgerald

(1.46)
# 3,191
Out of 5,173 analysts
2
Total ratings
50%
Success rate
0.89%
Average return

Stocks Rated by Olivia Brayer Saunders

Tenax Therapeutics
Mar 17, 2026
Initiates: Overweight
Price Target: $35
Current: $14.27
Upside: +145.27%
United Therapeutics
Mar 12, 2026
Maintains: Overweight
Price Target: $525$625
Current: $521.22
Upside: +19.91%